Healthcare Services

Desmoid Tumors Market Forecast to 2030: Trends and Developments

April 21, 2026April 21, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Is The Market Size Of The Desmoid Tumors Market Expected To Change From 2026 To 2030?

The desmoid tumors market size has seen robust expansion in recent years. It is projected to increase from $3.15 billion in 2025 to $3.35 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 6.1%. Historically, this growth can be ascribed to several factors, including limited awareness of rare tumors, a reliance on surgical methods, the lack of targeted drugs, the structure of hospital-based oncology care, and instances of delayed diagnosis.

The market for desmoid tumors is projected to experience substantial expansion in the coming years. This market is predicted to reach $4.42 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 7.2%. The anticipated growth during this period stems from progress in molecular therapies, an increase in rare disease pipelines, a rise in clinical trials, enhanced diagnostic imaging, and a proliferation of specialty centers. Key trends foreseen for the forecast period encompass a move towards non-surgical management, a heightened adoption of targeted molecular therapies, the development of watchful waiting approaches, an enlargement of multidisciplinary care frameworks, and an intensified commitment to rare disease research.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/report/desmoid-tumors-global-market-report

What Major Factors Are Driving The Desmoid Tumors Market Forward?

The increasing incidence of cancer is projected to stimulate the expansion of the desmoid tumor market. Cancer is characterized as a group of illnesses where abnormal cells in the body multiply and spread uncontrollably, potentially invading and harming surrounding tissues and organs. The global rise in cancer cases has intensified the requirement for advanced and potent chemotherapeutic agents, which in turn positively influences the desmoid tumor market. For example, in October 2025, the National Health Service (NHS), a UK-based government health agency, disclosed 354,820 new cancer diagnoses in 2023, equating to an average of 972 per day. This was 8,605 more diagnoses than recorded in 2022. Thus, the growing number of cancer cases is propelling the desmoid tumor market forward.

How Is The Desmoid Tumors Market Broken Down By Segment Categories?

The desmoid tumors market covered in this report is segmented –

1) By Treatment: Surgery, Radiation Therapy, Anti-Inflammatory Medication, Hormone Therapy, Chemotherapy, Novel Molecular-Targeted Therapy, Other Treatments

2) By Diagnosis: Biopsy, Electron Microscopic Examination, Immunohistochemical Analysis, Other Diagnosis

3) By End-User: Hospitals And Clinics, Specialty Centers, Other End-Users

Subsegments:

1) By Surgery: Wide Excision, Minimally Invasive Surgery

2) By Radiation Therapy: External Beam Radiation Therapy, Stereotactic Body Radiation Therapy

3) By Anti-Inflammatory Medication: Non-Steroidal Anti-Inflammatory Drugs (NSAIDS), Corticosteroids

4) By Hormone Therapy: Selective Estrogen Receptor Modulators (SERMs), Aromatase Inhibitors

5) By Chemotherapy: Traditional Chemotherapy Agents, Combination Chemotherapy

6) By Novel Molecular-Targeted Therapy: Tyrosine Kinase Inhibitors

7) By Other Treatments: Watchful Waiting, Physical Therapy, Pain Management Strategies

Which Trends Are Impacting The Progress Of The Desmoid Tumors Market?

Major companies within the desmoid tumors market are actively developing innovative drugs, such as nirogacestat, to better address the needs of their existing consumers for desmoid tumor treatment. Nirogacestat functions as an oral, small-molecule gamma-secretase inhibitor. For example, in February 2023, SpringWorks Therapeutics Inc., a clinical-stage biopharmaceutical company based in the US, announced that the U.S. Food and Drug Administration (FDA) had accepted and granted priority review to their new drug application (NDA) for nirogacestat, intended for the treatment of adults with desmoid tumors. Nirogacestat is believed to operate by inhibiting the production of notch proteins, a process that can result in the demise of tumor cells. Desmoid tumors are known to generate high levels of notch protein, which is thought to contribute to their proliferation. Furthermore, nirogacestat offers patients an additional treatment option that holds the potential to enhance their outcomes.

Which Players Are Present In The Desmoid Tumors Market Space?

Major companies operating in the desmoid tumors market are Pfizer Inc., F.Hoffmann-La Roche Ltd., AbbVie Inc., Bayer AG, Novartis AG, Amgen Inc., Eisai Limited, Incyte Corporation, Ipsen Biopharmaceuticals Inc., BeiGene Ltd., Janssen Biotech Inc., Blueprint Medicines Corporation, Debiopharm Group, Clovis Oncology Inc., SpringWorks Therapeutics Inc., Loxo Oncology Inc., Mirati Therapeutics Inc., Iterion Therapeutics Inc., Recepta Pharmaceuticals Inc., Cellestia Biotech AG

Get The Full Desmoid Tumors Market Report:

https://www.thebusinessresearchcompany.com/report/desmoid-tumors-global-market-report

Where Is The Desmoid Tumors Market Most Concentrated Geographically?

North America was the largest region in the desmoid tumors market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the desmoid tumors market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Desmoid Tumors Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/desmoid-tumors-global-market-report

Browse Through More Reports Similar to the Global Desmoid Tumors Market 2026, By The Business Research Company

Penile Cancer Market Report 2026

https://www.thebusinessresearchcompany.com/report/penile-cancer-global-market-report

Desiccants Market Report 2026

https://www.thebusinessresearchcompany.com/report/desiccants-global-market-report

Cancer Cachexia Market Report 2026

https://www.thebusinessresearchcompany.com/report/cancer-cachexia-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795